Veterinary Medicines

RHINANVAC CERDOS

Authorised
  • Bordetella bronchiseptica, strain S-4212, Inactivated
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
  • Pasteurella multocida, serotype D, strain P-934, Inactivated
  • Pasteurella multocida, serotype D, dermonecrotic toxin, recombinant
Download as PDF

Product identification

Medicine name:
RHINANVAC CERDOS
Active substance:
  • Bordetella bronchiseptica, strain S-4212, Inactivated
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
  • Pasteurella multocida, serotype D, strain P-934, Inactivated
  • Pasteurella multocida, serotype D, dermonecrotic toxin, recombinant
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain S-4212, Inactivated
    10.00
    antibody unit(s)
    /
    1.00
    Dose
  • Haemophilus parasuis, strain NCTC 4557, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mycoplasma hyopneumoniae, strain VMRI-11, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A2, strain NCTC 9380, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Pasteurella multocida, serotype D, strain P-934, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Pasteurella multocida, serotype D, dermonecrotic toxin, recombinant
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.U.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2879 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."